Cigna-Express Scripts Deal: 5 Takeaways for Health ExecsThe Cigna-Express Scripts deal may signal a move to more vertical and horizontal healthcare deals. Here’s what else it means.
Three Essentials Providers Need for Risk-Based ContractsThese core elements make up a collaborative “provider enablement” strategy to break down resistance to value-based care.
Five changes healthcare executives can expect in 2018The winds of change swept through healthcare in 2017. Here’s what 2018 could bring.
Pharmacy Is Dead
Pharmacy Is DeadThe CVS/Aetna deal won’t kill traditional pharmacy—it just shows that it’s already dead.
The CVS/Aetna Deal in 5 Quotes
The CVS/Aetna Deal in 5 QuotesNow that an official proposal has been announced, how are industry leaders responding?
Why Every Pharmacist Should Care About the CVS/Aetna Deal
Why Every Pharmacist Should Care About the CVS/Aetna DealEven if it doesn't happen, the deal says a lot about the current and future states of pharmacy.
Potential CVS-Aetna merger: Top 6 industry implicationsHealthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.
Potential CVS-Aetna merger: Key takeaways for health execsThe CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.
Opinion: Four reasons Texas Health Aetna joint venture is workingAs the industry moves to a value-based care model, here’s how one North Texas partnership is reinventing healthcare.
Pharmacists Pushing for DIR Relief
Pharmacists Pushing for DIR ReliefCommunity pharmacists fight against financial pressure for their survival.